Dow Chemical Co. (DOW) Tops Q2 EPS by 3c

Dow Chemical Co. (NYSE: DOW) reported Q2 EPS of $0.74, $0.03 better than the analyst estimate of $0.71. Revenue for the quarter came in at $14.92 billion versus the consensus estimate of $14.82 billion.

Commenting on the Company’s outlook, CEO Andrew Liveris said:

“Our operating priorities are delivering strong results despite ongoing slow growth and volatility in the global marketplace. We remain focused on these priorities as we continue to execute against our business-by-business plans – maximizing value through a balanced mix of differentiated technology and integrated, advantaged value chains.

“Strategically, our key high-return growth projects – such as the launch of Enlist™, the Sadara joint venture and our investments on the U.S. Gulf Coast – all remain on schedule and on budget, with 2015 serving as a major start-up year for all three.

“Simultaneously, we are focused on driving portfolio improvements – monetizing non-strategic businesses and releasing additional value from our assets and joint ventures. We are working on multiple fronts with multiple teams, with these efforts underlining our focus on creating value, and increasingly and consistently rewarding our shareholders.”

For earnings history and earnings-related data on Dow Chemical Co. (DOW) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Medtronic completes $550 million Scientia Vascular acquisition
• RH (RH) Tops Q1 EPS by 12c